Join us in Warsaw on June 24th, 2025, for the Brainlab Central Europe SRS & SBRT Symposium 2025. Experience an inspiring lineup of expert talks and engaging discussions on cutting-edge developments in radiotherapy and radiosurgery.
Highlights of the symposium:
- Discover advancements: Attend scientific talks and explore the latest techniques in precision, personalization, and standardization of SRS & SBRT.
- Join interactive sessions: Take part in live demonstrations and dynamic discussions that will shape the future of patient care.
- Network with experts: Engage with leading professionals in the field and connect with peers from across Central Europe.
We look forward to welcoming you to Warsaw this June! Click here to learn more: Welcome | Brainlab
Join us in Brussels for a vibrant evening with insightful clinical talks by renowned clinical experts and inspirational discussions on SRS & SBRT.
Experience cutting edge of radiotherapy and radiosurgery at our exciting sunset symposium focused on precision, personalization, and standardization in Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT). This event will bring together clinicians, medical physicists, and radiation oncologists to share valuable clinical techniques and innovative management strategies, as well as insights into the transformative impact of big data in the field of SRS & SBRT.
We look forward to welcoming you to Brussels for this inspiring event! Click here to learn more: Welcome | Brainlab
Join the Symposium!
The Brainlab UK & Ireland Radiotherapy Symposium 2024 will focus on precision, personalization and evolution in radiotherapy and radiosurgery.
Led by the Charing Cross Hospital team, this meeting is an opportunity for clinicians, medical physicists and radiation oncologists to share insights on clinical techniques, exchange management approaches, tools and the use of big data in radiotherapy and radiosurgery treatments.
Attendees have the opportunity to take part in scientific talks, live demonstrations and informative discussions.
We look forward to seeing you all in London!
To register click here
You are being invited to take part in a 15-minute survey assessing how radiation therapy and radiosurgery departments (including C-arm Linacs, Gammaknife, CyberKinfe, etc) , utilise MRI fibertracking (also known as MRI tractography) in their practice. (Link below)
This study is being run by Physical Sciences Department of Peter MacCallum Cancer Centre, Melbourne, Australia.
Upon request, we will provide you with the full anonymised survey results so that you can compare your practice with other participants.
This project has been approved by the Peter MacCallum Cancer Centre Ethics Committee (ethics@petermac.org).
If you have any questions, please don’t hesitate to send an email.
Participation agreement:
By clicking the link below, I agree to participate in this survey.
https://redcap.petermac.org.au/surveys/?s=AP4884J787EJRTLF
Thanks
Joao Gabriel R. Gomes, @Lucas Albino , @Karen Pieri , @Ernesto Henrique Roesler
Real Hospital Portugues de beneficencia em Pernambuco
@Lucas Albino , Joao Gabriel R Gomes, Karen Pieri, Ernesto Henrique Roesler
Real Hospital Portugues de beneficencia em Pernambuco
Together with our partner Varay, we are pleased to invite you to our Israel User Meeting in HERZLIYA ON SEA in Tel Aviv.
This meeting is an opportunity for clinicians, medical physicists and radiation oncologists to share clinical techniques and discuss management approaches, tools and Big Data insights in primary and metastatic oncological radiotherapy treatment.
We are thrilled to have the chance to reconnect with you in person.
We look forward to receiving and sharing your anonymized patient cases to be discussed with an extended network of experts in the field of SRS & SBRT.
Dear Colleagues
A 52 yo lady has a progression of residual disease after partial resection 5 months ago of a grade II meningioma of the falx. Unfortunately, at that time the patient did not accept treatment.
I would propose irradiating with FSRT the whole cavity and boosting with SRT the macroscopic disease. Would you share this opinion?
Would you go for further surgery?
The patient already reported partial lower limb palsy after the first operation
Thank a lot for your kind help
